Third Party Diagnostic Assays
Third Party Diagnostic Assays
Benefits of Randox Open Channel Reagents
Comprehensive Test Menu
–
A comprehensive test menu encompassing over 110 diagnostic assays, including a variety of assays unique to Randox
Superior Methodology
–
Superior methodologies ensuring accurate & reliable results compared to traditional methods
Reduce Costs
–
Versatile test menu enabling laboratories to reduce costs with in-house testing
Excellent Correlations
–
Excellent correlations to gold standard & commercial methods providing confidence in patient results
Dedicated Reagent Bottles
–
Availability of reagents in instrument dedicated bottles, reducing operator time
Applications Available
–
Applications are available detailing instrument-specific settings for the convenient use of Randox Reagents on a variety of clinical chemistry analysers
Randox Reagents cover a range of testing panels from cardiology & lipid testing to diabetes testing to veterinary testing. Browse our range of third party diagnostic testing panels by clicking on the images below.
Antioxidant Testing
Cardiology & Lipid Testing
Clinical Chemistry Testing
Diabetes Testing
Rapid Tests & Serology
Specific Proteins
Superior Performance & Unique Tests
Therapeutic Drug Monitoring
–
Easy Fit
We are dedicated to providing third party diagnostic tests that fit perfectly with your laboratory needs. In addition to providing an extensive test menu of the highest quality reagents, we also ensure flexibility, convenience and ease-of-use with our Easy Fit reagents bottles.
Open Channel
–
Clinical third party diagnostic tests optimised for open channel use on an extensive range of clinical chemistry analysers.
2 Step Process
–
A simple 2 step process enables you to actively run Randox Reagents on your clinical chemistry analyser.
Dedicated Bottles
–
Presented in bottles which fit easily onto your analyser.
Applications Available
–
Validated analyser applications ensure ease of programming and confidence in results.
Easy Read
To make your laboratory testing easier, Randox Reagents offer a range of clinical third party diagnostic tests with dedicated barcodes that are optimised for use on a range of specific clinical chemistry analysers.
Dedicated Bottles
–
Presented in bottles which fit easily onto your analyser.
Barcodes
–
Reagent bottles have specific barcodes enabling the analyser to read it automatically.
Simple Process
–
A simple process that saves time and improves laboratory efficiency.
Freedom of Choice
–
Offers you freedom of choice from an independent manufacturer.
Browse the Randox Reagents range of third party, open channel diagnostic tests.
Existing customers can access IFU’s through Product Inserts.
If you have any questions, please do not hesitate to Contact Us.
A-B
C-D
E-H
I-P
R-Z
Applications are available detailing instrument-specific settings for the convenient use of Randox Reagents on a variety of clinical chemistry analysers. Browse the sample range of diagnostic tests by analyser below.
We independently develop and manufacture dedicated reagents for automated systems to stimulate competition in performance and customer services for the benefit of all clients. All kits are produced to international standard and have ISO 13485 accreditation.
If you don’t see the application you are looking for, please Contact Us.
Existing customers can access IFU’s through Product Inserts.
Abbott Alinity
Beckman Coulter AU Systems including DxC700AU
Hitachi 917/Modular P
Mindray BS Series
Roche Cobas 4000 / 6000 / 8000
Siemens Atellica
Thermo Konelab 20i / 30i / 60i
Want to know more?
Contact us or download our Reagents brochure to learn more.
Related Products
Featured Reagent Home
Reagents Brochure
Reagents Resource Hub
Securing the future with in vitro diagnostic tests
The aim of Biomedical Science Day is to raise the public’s awareness of the importance of biomedical science and the vital role it plays in the world. Randox are dedicated to improving healthcare worldwide through placing a major focus on research and development. The Randox scientists work in pioneering research into a range of common illnesses such as cancer, cardiovascular disease and Alzheimer’s disease.
A recent blog from Doris-Ann Williams, the Chief Executive at BIVDA, explains how “increased funding is not enough to sustain the NHS” and how “we need to make better use of in vitro diagnostics to ensure a successful future”.
The National Health Service (NHS) is a publicly funded, primarily taxation, national healthcare system in the United Kingdom. It was first set-up on July 5th, 1948 by Aneurin Bevan as he believed that everyone, regardless of wealth, should have access to good healthcare. Whilst the NHS is an extremely important aspect of healthcare in the UK, in vitro diagnostics are the heart and soul of the healthcare system as healthcare professionals not only rely on blood tests to diagnose and treat patients, but also to rule out the different contributing causes to a disease state. In vitro diagnostics also plays a key role in monitoring chronic disease states. In vitro diagnostics can also aid in reducing hospital stays, reduce misdiagnosis and support patients in looking after their own health and to deliver personalised treatment plans.
The Randox scientists have developed several niche assays to improve patient diagnosis, monitor treatment and eliminate misdiagnosis.
Adiponectin
Adiponectin is a protein hormone secreted by adipocytes with anti-inflammatory and insulin-sensitising properties. It plays an important role in a number of metabolic processes including glucose regulation and fatty acid oxidation. Adiponectin levels are inversely correlated with abdominal visceral fat which have proven to be a strong predictor of several pathologies, including: metabolic syndrome, type 2 diabetes mellitus (T2DM), cancers and cardiovascular disease (CVD). For more information on the importance of testing Adiponectin levels, check out our Adiponectin Whitepaper.
Cystatin C
Cystatin C is an early risk marker for renal impairment. The most commonly run test for renal impairment is Creatinine. Creatinine measurements have proven to be inadequate as certain factors must be taken into consideration, including age, gender, ethnicity etc. The National Institute for Health and Care Excellence (NICE) have updated their guidelines, which now recommends Cystatin C as a more superior test for renal impairment due to its higher specificity for significant disease outcomes than those based on Creatinine. For more information on the importance of testing Cystatin C levels, check out our Cystatin C Whitepaper.
Small-dense LDL Cholesterol (sdLDL-C)
LDL Cholesterol (LDL-C) consists of two parts: the large and buoyant LDL Cholesterol and the small and dense LDL Cholesterol. Whilst all LDL-C transports triglycerides and cholesterol to bodily tissues, their atherogensis varies according to their size. As sdLDL-C is small and dense, they can more readily permeate the arterial wall and are more susceptible to oxidation. Research indicates that individuals with a predominance of sdLDL-C have a 3-fold increased risk of myocardial infarction. It has been noted that sdLDL-C carries less Cholesterol than large LDL, therefore a patient with predominately sdLDL-C particle may require nearly 70% more sdLDL-C particles to carry the same amount of cholesterol as the patient with predominately LDL-C particles. For more information on the importance of testing sdLDL-C levels, check out our sdLDL-C Whitepaper.
These three niche in vitro diagnostics tests developed by Randox scientists can aid in reducing NHS costs due to their higher performance compared to the traditional tests. Randox are constantly striving to improve healthcare worldwide.
For more information on the extensive range of Randox third-party in vitro diagnostic reagents, visit: https://www.randox.com/diagnostic-reagents/ or contact reagents@randox.com.
